The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

About one-third of EMS agencies in a nationally representative registry switched their advanced airway placement approach from 2016-2018 to 2020-2022. Survival and return of spontaneous circulation ...

A major cardiovascular risk factor is thickening of the heart walls (hypertrophy), which can result from high blood ...

AliveGen USA Inc. (AliveGen), a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that its investigational therapy ALG-801 delivered superior efficacy ...

In pulmonary hypertension (PH), upregulated signaling by ActRIIA ligands, such as myostatin, activin A and GDF11, activates SMAD2/3 mediated pathways that drive pulmonary vascular remodeling and right ...

Guidelines regarding the management of patients with valvular heart disease have been published by the European Society of Cardiology and EACTS.

Cardiovascular aging is a major contributor to the global burden of heart disease, characterized by structural remodeling, metabolic alterations, and a ...

Danicamtiv is an investigational selective agonist of cardiac myosin, intended to help myocyte contraction by enhancing cardiac myosin function and availability. As such, it is positioned as a ...

Stem cell-derived conditioned medium, the liquid that remains after cells are cultured, reduced PAH signs in rats and cells, ...

Abstract: Cardiovascular diseases (CVDs) are a leading cause of mortality worldwide, highlighting the critical need for accurate and continuous heart health monitoring. Electrocardiograms (ECG), ...

Scientists have uncovered the protective role of the protein GADD45A in guarding the heart from harmful stress responses. When the heart is placed under greater strain, its ventricular wall can ...